EXEL vs MRNA
Exelixis, Inc. - Common Stock · Moderna, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | EXEL | MRNA |
|---|---|---|
| Price | $60.99 | $226.30 |
| Market Cap | $15.11B | $90.35B |
| P/E | 19.31 | — |
| P/B | 8.20 | 13.36 |
| P/S | 6.51 | 46.47 |
| ROE | 42.4% | -41.7% |
| Net Margin | 33.7% | -145.2% |
| Gross Margin | — | — |
| Revenue Growth | 7.0% | -39.9% |
| Dividend Yield | — | — |
| EPS | $3.16 | -$7.07 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.